Answer:
- 5,000 watches : $150,000 loss
- 20,000 watches: $60,000 (Loss)
- Break-even point = 30,000 units
- if the selling price rises to 32 = break even points descends to 10,588 units
- If the selling price rises to $32 but variable costs rises to $26 , the break even point goes back to 30,000units.
Explanation:
Hi, to answer this question we have to apply the next formula:
Profit = Revenue -cost
Where the revenue is equal to the units sold (x) multiplied by the selling price,
R = 21 x
And cost is equal to the sum of the fixed and variable costs.
C = 15x + 1800
So:
P = 21x-(15x +180,000)
P = x ( 21-15)- 180,000
P = 5000(21-15)-180,000
P = 5000(6) -180,000
P= 30,000-180,000
P=-$150,000 (loss , since is negative )
P = 20,000(6) -180,000
P = 120,000-180,000
P=-$60,000 (Loss)
- To find the break even point:
R = C
21x = 15x + 180,000
21x-15x =180,000
6 x = 180,000
x = 180,000/6
x =30,000 units
- if the selling price rises to 32
32x = 15x + 180,000
32x-15x = 180,000
17x =180,000
x = 180,000/17
x = 10,588 units
It descends,
- If the selling price rises to $32 but variable costs rises to $26
32x = 26x+180,000
32x-26x = 180,000
6x = 180,000
x = 180,000/6
x =30,000
The break-even point comes back to 30,000 units.
Answer:
$800,000
Explanation:
The computation of the taxes paid by the company in 2013 is shown below:
Year Taxable Income Carry forward amount Year-end amount
2010 -$4,000,000 $0
2011 $1,000,000 - $4,000,000 $3,000,000
2012 $2,000,000 -$3,000,000 $1,000,000
2013 $3,000,000 -$1,000,000 $2,000,000
Now the tax paid is
= $2,000,000 × 40%
= $800,000
Answer and Explanation:
The following theories of profit best explain the profits of pharma companies:
1. Risk bearing - The theory says the higher the risk, the higher the rewards. The pharma companies take huge risks in inventing a new drug, having trials and the getting FDA approvals.
2. Monopoly - If a new drug is approved, the pharma company gets a patent over it, which means that it will have an effective monopoly on that segment of the market.
3. Innovation - it states that innovation is what keeps a company ahead. And pharma industry is built on innovation. Pharma companies have to continuously find new drugs because once patents run out on existing drugs, there are no profits to be made.
Answer: Joint venture
Explanation: A joint venture can be defined as a business entity, that is created by two or more firms by shared ownership or sharing in risk and returns. The joint venture is usually done by the firms for targeting new emerging markets to increase their customer base.
In the given case, Arboren is a new company and is formed by the joint ownership of three existing firms.
Hence, from the above we can conclude that this is an example of Joint venture.
Answer:
chart of accounts. a list of all account names used to record transactions of a company.
external transactions. transactions the firm conducts with a separate economic entity.
general ledger. all accounts used to record the company's transactions.
journal
posting
T-account
trial balance
accounts
